Pregnancy during nitisinone treatment for tyrosinaemia type I: First human experience

JIMD Reports

Volumn 5, Issue , 2012, Pages 27-33

  Vanclooster, A ^a   Devlieger, R ^a   Meersseman, W ^a   Spraul, A ^b   Kerckhove, K Vande ^a   Vermeersch, P ^a   Meulemans, A ^a   Allegaert, K ^a   Cassiman, D ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Amino acid mixture; Autosomal recessive disease; Fanconi syndrome; Fetal plasma; Phenylalanine level

Indexed keywords

EID: 84889634010     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2011_88     Document Type: Chapter

References (9)

1. Cerone R, Fantasia AR, Castellano E, Moresco L, Schiaffino MC, Gatti R (2002) Pregnancy and tyrosinaemia type II, case report. J inherit Metab Dis 25:317–318
2. Davit-Spraul A, Rhomdame H, Poggi-Bach J (2011) Simple and fast quantification of nitisone (NTBC) using liquid chromatography tandem mass spectrometry method in plasma of tyrosinemia type 1 patients. J Chromatogr Sci (in press).
3. Devlieger H, Martens G, Bekaert A, Eeckels R, Vlietinck R (1996) Perinatale activiteiten in Vlaanderen. 94–116 http://www.neo-natologie.ugent.be/SPE-standaarden.pdf. Accessed 31 May 2011
4. Francis DE, Kirby DM, Thompson GN (1992) Maternal tyrosinaemia II: management and successful outcome. Eur J Pediatr 151:196–9
5. Grompe M (2001) The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis 21:563–571
6. Kvittingen EA, Holme E (2000) Disorder of tyrosine metabolism. In: Fernandes J, Saudubray JM, Van den Berghe G (eds) Inborn metabolic diseases, diagnosis and treatment. Springer, Germany, pp 186–194
7. Mitchell GA, Grompe M, Lambert M, Tanguay RM (2001) Hyper-tyrosinemia, in Scriver CR, Beadudet AL, Sly WS, Valle D (eds) The Metabolic & Molecular Bases of Inherited Disease, 8th Ed, MCcGraw-Hill, New York, p 1778
8. Schoonheyt WE, Clarke JT, Hanley WB, Johnson JM, Lehotay DC (1994) Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin Chim Acta 225:165–9
9. Scott CR (2006) The genetic tyrosinemias. Am J Med Genet C 142C:121–126